Compagnie Lombard Odier SCmA’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.9M Sell
190,007
-26,791
-12% -$1.87M 0.15% 79
2025
Q4
$14.4M Buy
216,798
+34,406
+19% +$2.22M 0.16% 75
2025
Q3
$12.3M Sell
182,392
-720
-0.4% -$57K 0.14% 81
2025
Q2
$16M Buy
183,112
+53,092
+41% +$4.16M 0.21% 67
2025
Q1
$8.88M Sell
130,020
-4,790
-4% -$391K 0.11% 91
2024
Q4
$10.5M Sell
134,810
-16,473
-11% -$1.22M 0.15% 74
2024
Q3
$10.1M Sell
151,283
-4,431
-3% -$364K 0.16% 77
2024
Q2
$17.7M Buy
155,714
+3,099
+2% +$392K 0.3% 60
2024
Q1
$21.2M Buy
152,615
+25,700
+20% +$3.23M 0.37% 55
2023
Q4
$15.7M Buy
126,915
+22,942
+22% +$2.34M 0.29% 70
2023
Q3
$9.7M Buy
103,973
+70,923
+215% +$7.99M 0.22% 69
2023
Q2
$4.25M Buy
33,050
+17,972
+119% +$2.17M 0.12% 82
2023
Q1
$1.75M Buy
15,078
+6,333
+72% +$709K 0.04% 134
2022
Q4
$991K Buy
8,745
+6,069
+227% +$666K 0.03% 155
2022
Q3
$216K Hold
2,676
0.01% 287
2022
Q2
$199K Sell
2,676
-604
-18% -$55.1K 0.01% 293
2022
Q1
$420K Buy
3,280
+2,200
+204% +$241K 0.01% 233
2021
Q4
$146K Sell
1,080
-1,000
-48% -$144K ﹤0.01% 399
2021
Q3
$285K Buy
2,080
+1,000
+93% +$126K 0.01% 312
2021
Q2
$116K Hold
1,080
﹤0.01% 396
2021
Q1
$97K Hold
1,080
﹤0.01% 448
2020
Q4
$100K Hold
1,080
﹤0.01% 386
2020
Q3
$111K Sell
1,080
-320
-23% -$33.4K ﹤0.01% 328
2020
Q2
$142K Sell
1,400
-600
-30% -$53.7K ﹤0.01% 299
2020
Q1
$135K Hold
2,000
0.01% 273
2019
Q4
$109K Hold
2,000
﹤0.01% 305
2019
Q3
$75K Sell
2,000
-800
-29% -$31.1K ﹤0.01% 332
2019
Q2
$105K Buy
2,800
+800
+40% +$25.1K ﹤0.01% 299
2019
Q1
$60K Sell
2,000
-26,100
-93% -$917K ﹤0.01% 389
2018
Q4
$842K Sell
28,100
-1,803,084
-98% -$57.2M 0.03% 163
2018
Q3
$65.5M Sell
1,831,184
-594,952
-25% -$18.4M 2.29% 11
2018
Q2
$57.6M Sell
2,426,136
-634,024
-21% -$13.4M 2.11% 13
2018
Q1
$56.7M Sell
3,060,160
-4,024,072
-57% -$59.5M 2.07% 14
2017
Q4
$102M Buy
7,084,232
+3,701,032
+109% +$48.1M 1.83% 13
2017
Q3
$41.4M Buy
3,383,200
+222,668
+7% +$3.94M 1.47% 16
2017
Q2
$57.8M Buy
3,160,532
+108,344
+4% +$2M 2% 11
2017
Q1
$64.7M Sell
3,052,188
-415,816
-12% -$8.12M 2.18% 11
2016
Q4
$51.8M Buy
3,468,004
+1,545,412
+80% +$27.4M 1.52% 16
2016
Q3
$42.1M Buy
+1,922,592
New +$42.8M 1.23% 19

Other funds holding DXCM

Compagnie Lombard Odier SCmA's DXCM Position: Q1 2026 in Review

Compagnie Lombard Odier SCmA reduced its DexCom (DXCM) stake by 12% in Q1 2026, selling an estimated $1.87M and leaving 190,007 shares worth $11.9M. The position accounts for 0.15% of the portfolio, ranked #79.

Compagnie Lombard Odier SCmA first reported a position in DXCM in Q3 2016 and has held it in 39 quarters since. The position peaked at $102M in Q4 2017. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Compagnie Lombard Odier SCmA held 190,007 shares of DexCom worth $11.9M as of Q1 2026.
  • Compagnie Lombard Odier SCmA sold 26,791 DexCom shares in Q1 2026, an estimated $1.87M.
  • DexCom made up 0.15% of Compagnie Lombard Odier SCmA's portfolio in Q1 2026, its #79 holding.
  • Compagnie Lombard Odier SCmA first reported a position in DexCom in Q3 2016 and has held it in 39 quarters since.
  • Compagnie Lombard Odier SCmA's DexCom position peaked at $102M in Q4 2017.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q1 2026, filed 15 Apr 2026.